Excited to share an interview featuring our Founder & CEO, Matt Schecter, with Houlihan Lokey’s Managing Director, Mark Martin, for their inaugural Thought Leader Interview Series. They discussed our company’s engagement with HCPs during the pre-approval process, the impact of FDA approval slowdowns, the evolution of the industry landscape, and more. Click here to read the interview.
Our entire company was live and in person at the Mohegan Sun in Connecticut for our annual Year Beginning Meeting (YBM). Each year, we come together to learn, reconnect, and recognize each other’s success and accomplishments. In the spirit of this year’s theme, Better Together, many of our sessions were centered around the power of working as a team and embracing our people-first mentality. We celebrated Martin Luther King Jr. Day together with a day of service, assembling over 100 care packages for our troops overseas. We couldn't be more grateful to kick-off another year with such an amazing group of people!
As the year comes to an end, we are humbled to reflect on the amazing year we've had with our clients and team members. Thank you to all who made 2022 such a great year!
Check out the latest addition to The Lockwood Group, Random42.
Where the world of science, art, and technology intertwine, we are thrilled to bring our clients new best-in-class, innovative, capabilities.
We are thrilled to announce the expansion of The Lockwood Group, with a strategic investment in Random42 Scientific Communication, a best-in-class medical animation studio based in London, England. Please join us in welcoming Random42 to the Lockwood Family!
We are excited to be named one of the Financial Times Americas' Fastest Growing Companies for a third consecutive year! This prestigious award honors 500 outstanding companies among the millions of North and South American enterprises, and we are humbled to continue to be one of them!
